Alzheimer’s disease market expected to reach $14.7bn across the 8MM by 2033
A major focus of R&D in the Alzheimer’s disease therapeutic space is preventing the accumulation of amyloid beta.
A major focus of R&D in the Alzheimer’s disease therapeutic space is preventing the accumulation of amyloid beta.